Jin-Young Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jin-Young Kim has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- Hongsoo Choi
Department of Biomedical Engineering University of Massachusetts Amherst Massachusetts USA
11 shared publications - Awais Ahmed
Department of Robotics and Mechatronics Engineering and the DGIST-ETH Microrobotics Research Center, Daegu Gyeongbuk Institute of Science and Technology, Daegu, South Korea
3 shared publications - Chaewon Jin
Division of Biomedical Technology, DGIST, Techno jungang-daero 333, Hyeonpung-eup, Dalseong-gun, Daegu 42988, Republic of Korea
3 shared publications - Sarmad Ahmad Abbasi
Department of Robotics and Mechatronics Engineering, and DGIST-ETH Microrobot Research Center, Daegu Gyeongbuk Institute of Science and Technology, Daegu, South Korea
3 shared publications - Bradley J. Nelson
Multi-Scale Robotics Lab, ETH Zurich, Zurich, Switzerland
2 shared publications - Cheil Moon
Department of Brain Sciences, Graduate School, Daegu Gyeongbuk Institute of Science and Technology (DGIST), Daegu, Republic of Korea
2 shared publications
Latest Publications
- 11 March 2026
- Published by American Chemical Society (ACS) in ACS Pharmacology & Translational Science
- Vol. 9 (4) , 925-933
A Simple and Robust Microfluidic Glomerular Filtration Barrier-on-a-Chip Platform for Investigating Drug-Induced Nephrotoxicity
The glomerulus is the filtering unit of the kidney, and the glomerular filtration barrier (GFB) is responsible for filtering waste, retaining plasma protein, and maintaining fluid balance. Drug-induced nephrotoxicity is characterized by dysfunction of the GFB and is a main obstacle in the new therapeutic screening process. This paper presents the simple and robust SLAS (Society of Laboratory Automation and Society) standard format-based microfluidic GFB-on-a-chip (GFBoC). We formed and cultured the GFB by aligning human glomerular mesangial cells (gMCs), podocytes, and glomerular endothelial cells (gECs) on each side of a conventional transwell membrane as the glomerular basement membrane (GBM). This provides facile loading/unloading of the GFB transwell into the microfluidic chip, enabling its cultivation under pump-/tubing-less perfusion flow and additional off-chip bioanalysis. It also allows various and multiple experiments in parallel in a conventional incubator at moderate operation complexity. Glomerular selective permeability of the GFB was characterized by filtration and leakage of the representative macromolecule, albumin, via the GFB, while the drug doxorubicin affected the GFB during cultivation in the GFBoC. This demonstrated that the GFBoC has potential as a simple, robust, and efficient platform for the multiple testing of nephrotoxicity and kidney disease drugs in parallel.
- 11 March 2026
- Published by American Chemical Society (ACS) in ACS Pharmacology & Translational Science
- Vol. 9 (4) , 925-933
A Simple and Robust Microfluidic Glomerular Filtration Barrier-on-a-Chip Platform for Investigating Drug-Induced Nephrotoxicity
The glomerulus is the filtering unit of the kidney, and the glomerular filtration barrier (GFB) is responsible for filtering waste, retaining plasma protein, and maintaining fluid balance. Drug-induced nephrotoxicity is characterized by dysfunction of the GFB and is a main obstacle in the new therapeutic screening process. This paper presents the simple and robust SLAS (Society of Laboratory Automation and Society) standard format-based microfluidic GFB-on-a-chip (GFBoC). We formed and cultured the GFB by aligning human glomerular mesangial cells (gMCs), podocytes, and glomerular endothelial cells (gECs) on each side of a conventional transwell membrane as the glomerular basement membrane (GBM). This provides facile loading/unloading of the GFB transwell into the microfluidic chip, enabling its cultivation under pump-/tubing-less perfusion flow and additional off-chip bioanalysis. It also allows various and multiple experiments in parallel in a conventional incubator at moderate operation complexity. Glomerular selective permeability of the GFB was characterized by filtration and leakage of the representative macromolecule, albumin, via the GFB, while the drug doxorubicin affected the GFB during cultivation in the GFBoC. This demonstrated that the GFBoC has potential as a simple, robust, and efficient platform for the multiple testing of nephrotoxicity and kidney disease drugs in parallel.
- 24 February 2026
- Published by American Chemical Society (ACS) in ACS Pharmacology & Translational Science
- Vol. 9 (3) , 636-645
96-Well Format-Based Liver–Heart-on-a-Chip Platform for Facile and Parallel Testing of Drug-Induced Cardiotoxicity after Liver Metabolism
Current preclinical drug evaluation predominantly relies on conventional two-dimensional (2D) cell cultures grown in static environments, which lack dynamic interactions and fail to recapitulate complex microenvironments. These approaches are inefficient and overly simplistic, and often require costly animal models that poorly mimic human physiology. Body-on-a-chip (BoC) technology─comprising robust and flexible three-dimensional (3D) microtissues (MTs)─has emerged to address these limitations. BoC platforms constitute microphysiological systems that mimic human organ physiology and function in vitro, enabling improved toxicity screening and personalized medicine. Here, we present a 96–well format-based microfluidic liver–heart-on-a-chip platform that supports parallel, gravity-driven perfusion to efficiently predict and assess multiorgan drug effects. We demonstrate hepatic metabolism of the cardiotoxic prodrug terfenadine (TFND) into its noncardiotoxic metabolite fexofenadine within liver MTs and the consequent physiological–pathological responses of cardiac MTs. The optimized liver–heart-on-a-chip preserves multitissue functionality, underscores the importance of continuous media circulation, and reveals intertissue interactions relevant to drug-induced cardiotoxicity after liver metabolism.
- 24 February 2026
- Published by American Chemical Society (ACS) in ACS Pharmacology & Translational Science
- Vol. 9 (3) , 636-645
96-Well Format-Based Liver–Heart-on-a-Chip Platform for Facile and Parallel Testing of Drug-Induced Cardiotoxicity after Liver Metabolism
Current preclinical drug evaluation predominantly relies on conventional two-dimensional (2D) cell cultures grown in static environments, which lack dynamic interactions and fail to recapitulate complex microenvironments. These approaches are inefficient and overly simplistic, and often require costly animal models that poorly mimic human physiology. Body-on-a-chip (BoC) technology─comprising robust and flexible three-dimensional (3D) microtissues (MTs)─has emerged to address these limitations. BoC platforms constitute microphysiological systems that mimic human organ physiology and function in vitro, enabling improved toxicity screening and personalized medicine. Here, we present a 96–well format-based microfluidic liver–heart-on-a-chip platform that supports parallel, gravity-driven perfusion to efficiently predict and assess multiorgan drug effects. We demonstrate hepatic metabolism of the cardiotoxic prodrug terfenadine (TFND) into its noncardiotoxic metabolite fexofenadine within liver MTs and the consequent physiological–pathological responses of cardiac MTs. The optimized liver–heart-on-a-chip preserves multitissue functionality, underscores the importance of continuous media circulation, and reveals intertissue interactions relevant to drug-induced cardiotoxicity after liver metabolism.
Shortwave Infrared Imaging of a Quantum Dot‐Based Magnetic Guidewire Toward Non‐Fluoroscopic Peripheral Vascular Interventions
Peripheral vascular interventions (PVIs) offer several benefits to patients with lower extremity arterial diseases, including reduced pain, simpler anesthesia, and shorter recovery time, compared to open surgery. However, to monitor the endovascular tools inside the body, PVIs are conducted under X‐ray fluoroscopy, which poses serious long‐term health risks to physicians and patients. Shortwave infrared (SWIR) imaging of quantum dots (QDs) has shown great potential in bioimaging due to the non‐ionizing penetration of SWIR light through tissues. In this paper, a QD‐based magnetic guidewire and its system is introduced that allows X‐ray‐free detection under SWIR imaging and precise steering via magnetic manipulation. The QD magnetic guidewire contains a flexible silicone tube encapsulating a QD polydimethylsiloxane (PDMS) composite, where HgCdSe/HgS/CdS/CdZnS/ZnS/SiO 2 core/multi‐shell QDs are dispersed in the PDMS matrix for SWIR imaging upon near‐infrared excitation, as well as a permanent magnet for magnetic steering. The SWIR penetration of the QD magnetic guidewire is investigated within an artificial tissue model (1% Intralipid) and explore the potential for non‐fluoroscopic PVIs within a vascular phantom model. The QD magnetic guidewire is biocompatible in its entirety, with excellent resistance to photobleaching and chemical alteration, which is a promising sign for its future clinical implementation.
Shortwave Infrared Imaging of a Quantum Dot‐Based Magnetic Guidewire Toward Non‐Fluoroscopic Peripheral Vascular Interventions
Peripheral vascular interventions (PVIs) offer several benefits to patients with lower extremity arterial diseases, including reduced pain, simpler anesthesia, and shorter recovery time, compared to open surgery. However, to monitor the endovascular tools inside the body, PVIs are conducted under X‐ray fluoroscopy, which poses serious long‐term health risks to physicians and patients. Shortwave infrared (SWIR) imaging of quantum dots (QDs) has shown great potential in bioimaging due to the non‐ionizing penetration of SWIR light through tissues. In this paper, a QD‐based magnetic guidewire and its system is introduced that allows X‐ray‐free detection under SWIR imaging and precise steering via magnetic manipulation. The QD magnetic guidewire contains a flexible silicone tube encapsulating a QD polydimethylsiloxane (PDMS) composite, where HgCdSe/HgS/CdS/CdZnS/ZnS/SiO 2 core/multi‐shell QDs are dispersed in the PDMS matrix for SWIR imaging upon near‐infrared excitation, as well as a permanent magnet for magnetic steering. The SWIR penetration of the QD magnetic guidewire is investigated within an artificial tissue model (1% Intralipid) and explore the potential for non‐fluoroscopic PVIs within a vascular phantom model. The QD magnetic guidewire is biocompatible in its entirety, with excellent resistance to photobleaching and chemical alteration, which is a promising sign for its future clinical implementation.
- Top Cited Papers
- 10 January 2024
- Published by Springer Nature in Nature Machine Intelligence
- Vol. 6 (1) , 92-105
Autonomous 3D positional control of a magnetic microrobot using reinforcement learning
- 10 January 2024
- Published by Springer Nature in Nature Machine Intelligence
- Vol. 6 (1) , 92-105
Top Cited PapersAutonomous 3D positional control of a magnetic microrobot using reinforcement learning
- Open Access
- 5 April 2023
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Access
- Vol. 11, 35327-35335
Electromagnetic Manipulation System for Semi-Autonomous Control of Small-Scale Magnetic Objects With Sequential Programming
In this study, an electromagnetic coil system was developed for semi-autonomous manipulation of microrobots in three-dimensional (3D) space with sequential programming. Cylindrical-shaped cores were used for the electromagnetic coils; the coils were arranged in a hemispherical configuration to allow open access to the workspace for imaging tools. The system consisted of four main parts: the electromagnetic coils, an electronic control unit, optical cameras, and a direct-manipulation graphical user interface (GUI). The system was capable of producing a magnetic field of up to 18 mT with a maximum current of 8 A current. Using this system, magnetic force and torque can be applied for semi-autonomous manipulation of magnetic objects, with different time intervals, by instantly inputting the required fields and gradients via the GUI. Sequential programming of the magnetic field allowed for better controllability and enhanced the repeatability of the system. The versatility of the system was demonstrated by moving a magnetic guidewire, micromagnet, and nanoparticles to their intended targets to assess the potential application of the system in biomedical fields.
- 5 April 2023
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Access
- Vol. 11, 35327-35335
Open AccessElectromagnetic Manipulation System for Semi-Autonomous Control of Small-Scale Magnetic Objects With Sequential Programming
In this study, an electromagnetic coil system was developed for semi-autonomous manipulation of microrobots in three-dimensional (3D) space with sequential programming. Cylindrical-shaped cores were used for the electromagnetic coils; the coils were arranged in a hemispherical configuration to allow open access to the workspace for imaging tools. The system consisted of four main parts: the electromagnetic coils, an electronic control unit, optical cameras, and a direct-manipulation graphical user interface (GUI). The system was capable of producing a magnetic field of up to 18 mT with a maximum current of 8 A current. Using this system, magnetic force and torque can be applied for semi-autonomous manipulation of magnetic objects, with different time intervals, by instantly inputting the required fields and gradients via the GUI. Sequential programming of the magnetic field allowed for better controllability and enhanced the repeatability of the system. The versatility of the system was demonstrated by moving a magnetic guidewire, micromagnet, and nanoparticles to their intended targets to assess the potential application of the system in biomedical fields.
- 19 January 2023
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 95 (6) , 3153-3159
A Microfluidic System for Investigating Anticipatory Medication Effects on Dopamine Homeostasis in Dopaminergic Cells
Dopamine (DA) homeostasis influences emotions, neural circuit development, cognition, and the reward system. Dysfunctions in DA regulation can lead to neurological disorders, including depression, developmental disorders, and addiction. DA homeostasis disruption is a primary cause of Parkinson's Disease (PD). Therefore, understanding the relationship between DA homeostasis and PD progression may clarify the mechanisms for pharmacologically treating PD. This study developed a novel in vitro DA homeostasis platform which consists of three main parts: (1) a microfluidic device for culturing DAergic neurons, (2) an optical detection system for reading DA levels, and (3) an automatic closed-loop control system that establishes when and how much medication to infuse; this uses a microfluidic device that can cultivate DAergic neurons, perfuse solutions, perform in vitro PD modeling, and continuously monitor DA concentrations. The automatically controlled closed-loop control system simultaneously monitors pharmacological PD treatment to support long-term monitoring of DA homeostasis. SH-SY5Y neuroblastoma cells were chosen as DAergic neurons. They were cultivated in the microfluidic device, and real-time cellular DA level measurements successfully achieved long-term monitoring and modulation of DA homeostasis. When applied in combination with multiday cell culture, this advanced system can be used for drug screening and fundamental biological studies.
- 19 January 2023
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 95 (6) , 3153-3159
A Microfluidic System for Investigating Anticipatory Medication Effects on Dopamine Homeostasis in Dopaminergic Cells
Dopamine (DA) homeostasis influences emotions, neural circuit development, cognition, and the reward system. Dysfunctions in DA regulation can lead to neurological disorders, including depression, developmental disorders, and addiction. DA homeostasis disruption is a primary cause of Parkinson's Disease (PD). Therefore, understanding the relationship between DA homeostasis and PD progression may clarify the mechanisms for pharmacologically treating PD. This study developed a novel in vitro DA homeostasis platform which consists of three main parts: (1) a microfluidic device for culturing DAergic neurons, (2) an optical detection system for reading DA levels, and (3) an automatic closed-loop control system that establishes when and how much medication to infuse; this uses a microfluidic device that can cultivate DAergic neurons, perfuse solutions, perform in vitro PD modeling, and continuously monitor DA concentrations. The automatically controlled closed-loop control system simultaneously monitors pharmacological PD treatment to support long-term monitoring of DA homeostasis. SH-SY5Y neuroblastoma cells were chosen as DAergic neurons. They were cultivated in the microfluidic device, and real-time cellular DA level measurements successfully achieved long-term monitoring and modulation of DA homeostasis. When applied in combination with multiday cell culture, this advanced system can be used for drug screening and fundamental biological studies.
- 26 December 2022
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Instrumentation and Measurement
- Vol. 72 (00189456) , 1-9
MagMaps: An Economical, Lego-Like Approach for Real-Time Magnetic Field Mapping Using Commercial Magnetic Sensors
Magnetic field mapping is tedious; a magnetometer probe collects magnetic field data in a point-by-point manner within a two-dimensional (2D) or three-dimensional (3D) space. Magnetometer arrays accelerate this process by replacing point-by-point mapping with plane-by-plane mapping. When mapping a large space, a motorized stage is additionally required; the limitations include power inefficiencies, large footprints, cost, and the absence of real-time data acquisition. Here, we introduce MagMaps, a modular Lego-like approach to magnetic field mapping that overcomes the limitations described above. MagMaps includes a set of physically identical modules termed “MagBricks” that can be stacked in all three axes (similar to Lego bricks); this covers the region of interest and eliminates the need for a motorized stage. Each MagBrick is an independent enslaved module with a unique address, having a microcontroller that continuously acquires magnetic field data from a magnetometer array. An additional brick termed the “MasterBrick” serves as a bridge between the computer and the MagBricks. The MasterBrick collects magnetic field data from uniquely addressed MagBricks and communicates them to a computer, where they are sorted and displayed in real-time. This modular Lego-like approach and the use of only off-the-shelf electronic components allows MagMaps to offer real-time magnetic field mapping that is portable, power-efficient, and economical for various 2D or 3D spaces.
- 26 December 2022
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Instrumentation and Measurement
- Vol. 72 (00189456) , 1-9
MagMaps: An Economical, Lego-Like Approach for Real-Time Magnetic Field Mapping Using Commercial Magnetic Sensors
Magnetic field mapping is tedious; a magnetometer probe collects magnetic field data in a point-by-point manner within a two-dimensional (2D) or three-dimensional (3D) space. Magnetometer arrays accelerate this process by replacing point-by-point mapping with plane-by-plane mapping. When mapping a large space, a motorized stage is additionally required; the limitations include power inefficiencies, large footprints, cost, and the absence of real-time data acquisition. Here, we introduce MagMaps, a modular Lego-like approach to magnetic field mapping that overcomes the limitations described above. MagMaps includes a set of physically identical modules termed “MagBricks” that can be stacked in all three axes (similar to Lego bricks); this covers the region of interest and eliminates the need for a motorized stage. Each MagBrick is an independent enslaved module with a unique address, having a microcontroller that continuously acquires magnetic field data from a magnetometer array. An additional brick termed the “MasterBrick” serves as a bridge between the computer and the MagBricks. The MasterBrick collects magnetic field data from uniquely addressed MagBricks and communicates them to a computer, where they are sorted and displayed in real-time. This modular Lego-like approach and the use of only off-the-shelf electronic components allows MagMaps to offer real-time magnetic field mapping that is portable, power-efficient, and economical for various 2D or 3D spaces.
- 23 June 2021
- Published by Wiley in Advanced Healthcare Materials
- Vol. 10 (19) , 2100801
A Magnetically Powered Stem Cell‐Based Microrobot for Minimally Invasive Stem Cell Delivery via the Intranasal Pathway in a Mouse Brain
Targeted stem cell delivery with microrobots has emerged as a potential alternative therapeutic strategy in regenerative medicine, and intranasal administration is an effective approach for minimally invasive delivery of therapeutic agents into the brain. In this study, a magnetically powered stem cell‐based microrobot (“Cellbot”) is used for minimally invasive targeted stem cell delivery to the brain through the intranasal passage. The Cellbot is developed by internalizing superparamagnetic iron oxide nanoparticles (SPIONs) into human nasal turbinate stem cells. The SPIONs have no influence on hNTSC characteristics, including morphology, cell viability, and neuronal differentiation. The Cellbots are capable of proliferation and differentiation into neurons, neural precursor cells, and neurogliocytes. The Cellbots in the microfluidic channel can be reliably manipulated by an external magnetic field for orientation and position control. Using an ex vivo model based on brain organoids, it is determined that the Cellbots can be transplanted into brain tissue. Using a murine model, it is demonstrated that the Cellbots can be intranasally administered and magnetically guided to the target tissue in vivo. This approach has the potential to effectively treat central nervous system disorders in a minimally invasive manner.
- 23 June 2021
- Published by Wiley in Advanced Healthcare Materials
- Vol. 10 (19) , 2100801
A Magnetically Powered Stem Cell‐Based Microrobot for Minimally Invasive Stem Cell Delivery via the Intranasal Pathway in a Mouse Brain
Targeted stem cell delivery with microrobots has emerged as a potential alternative therapeutic strategy in regenerative medicine, and intranasal administration is an effective approach for minimally invasive delivery of therapeutic agents into the brain. In this study, a magnetically powered stem cell‐based microrobot (“Cellbot”) is used for minimally invasive targeted stem cell delivery to the brain through the intranasal passage. The Cellbot is developed by internalizing superparamagnetic iron oxide nanoparticles (SPIONs) into human nasal turbinate stem cells. The SPIONs have no influence on hNTSC characteristics, including morphology, cell viability, and neuronal differentiation. The Cellbots are capable of proliferation and differentiation into neurons, neural precursor cells, and neurogliocytes. The Cellbots in the microfluidic channel can be reliably manipulated by an external magnetic field for orientation and position control. Using an ex vivo model based on brain organoids, it is determined that the Cellbots can be transplanted into brain tissue. Using a murine model, it is demonstrated that the Cellbots can be intranasally administered and magnetically guided to the target tissue in vivo. This approach has the potential to effectively treat central nervous system disorders in a minimally invasive manner.
- Open Access
- 25 September 2020
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 6 (39) , eabb5696
A magnetically actuated microrobot for targeted neural cell delivery and selective connection of neural networks
A magnetically controlled microrobot is used for an artificial neural network by connecting neural clusters.
- 25 September 2020
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 6 (39) , eabb5696
Open AccessA magnetically actuated microrobot for targeted neural cell delivery and selective connection of neural networks
A magnetically controlled microrobot is used for an artificial neural network by connecting neural clusters.
- 10 July 2019
- Published by Wiley in Advanced Healthcare Materials
- Vol. 8 (16) , e1900213
Magnetically Actuated Degradable Microrobots for Actively Controlled Drug Release and Hyperthermia Therapy
Microrobots facilitate targeted therapy due to their small size, minimal invasiveness, and precise wireless control. A degradable hyperthermia microrobot (DHM) with a 3D helical structure is developed, enabling actively controlled drug delivery, release, and hyperthermia therapy. The microrobot is made of poly(ethylene glycol) diacrylate (PEGDA) and pentaerythritol triacrylate (PETA) and contains magnetic Fe3O4 nanoparticles (MNPs) and 5‐fluorouracil (5‐FU). Its locomotion is remotely and precisely controlled by a rotating magnetic field (RMF) generated by an electromagnetic actuation system. Drug‐free DHMs reduce the viability of cancer cells by elevating the temperature under an alternating magnetic field (AMF), a hyperthermic effect. 5‐FU is released from the proposed DHMs in normal‐, high‐burst‐, and constant‐release modes, controlled by the AMF. Finally, actively controlled drug release from the DHMs in normal‐ and high‐burst‐release mode results in a reduction in cell viability. The reduction in cell viability is of greater magnitude in high‐burst‐ than in normal‐release mode. In summary, biodegradable DHMs have potential for actively controlled drug release and hyperthermia therapy.
- 10 July 2019
- Published by Wiley in Advanced Healthcare Materials
- Vol. 8 (16) , e1900213
Magnetically Actuated Degradable Microrobots for Actively Controlled Drug Release and Hyperthermia Therapy
Microrobots facilitate targeted therapy due to their small size, minimal invasiveness, and precise wireless control. A degradable hyperthermia microrobot (DHM) with a 3D helical structure is developed, enabling actively controlled drug delivery, release, and hyperthermia therapy. The microrobot is made of poly(ethylene glycol) diacrylate (PEGDA) and pentaerythritol triacrylate (PETA) and contains magnetic Fe3O4 nanoparticles (MNPs) and 5‐fluorouracil (5‐FU). Its locomotion is remotely and precisely controlled by a rotating magnetic field (RMF) generated by an electromagnetic actuation system. Drug‐free DHMs reduce the viability of cancer cells by elevating the temperature under an alternating magnetic field (AMF), a hyperthermic effect. 5‐FU is released from the proposed DHMs in normal‐, high‐burst‐, and constant‐release modes, controlled by the AMF. Finally, actively controlled drug release from the DHMs in normal‐ and high‐burst‐release mode results in a reduction in cell viability. The reduction in cell viability is of greater magnitude in high‐burst‐ than in normal‐release mode. In summary, biodegradable DHMs have potential for actively controlled drug release and hyperthermia therapy.